1,700 Intuitive Surgical, Inc. $ISRG Shares Purchased by WoodTrust Financial Corp

WoodTrust Financial Corp increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.8% in the third quarter, Holdings Channel.com reports. The firm owned 5,870 shares of the medical equipment provider’s stock after purchasing an additional 1,700 shares during the quarter. WoodTrust Financial Corp’s holdings in Intuitive Surgical were worth $2,387,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the company. Douglas Lane & Associates LLC boosted its position in shares of Intuitive Surgical by 112.6% during the third quarter. Douglas Lane & Associates LLC now owns 102,898 shares of the medical equipment provider’s stock valued at $41,842,000 after buying an additional 54,499 shares during the period. Breakwater Capital Group purchased a new stake in shares of Intuitive Surgical in the third quarter worth approximately $203,000. Legacy Wealth Asset Management LLC raised its holdings in shares of Intuitive Surgical by 62.9% in the third quarter. Legacy Wealth Asset Management LLC now owns 4,857 shares of the medical equipment provider’s stock worth $1,975,000 after buying an additional 1,876 shares during the period. LifeGoal Investments LLC purchased a new stake in shares of Intuitive Surgical in the third quarter worth approximately $335,000. Finally, Mn Services Vermogensbeheer B.V. lifted its stake in shares of Intuitive Surgical by 1.2% during the 3rd quarter. Mn Services Vermogensbeheer B.V. now owns 104,678 shares of the medical equipment provider’s stock worth $42,565,000 after acquiring an additional 1,200 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Barclays upgraded Intuitive Surgical to “strong buy” after initiating coverage with an overweight view. The firm reportedly considers ISRG a high-quality medical-equipment company, offering a positive catalyst for investor sentiment. Intuitive Surgical upgraded at Barclays
• Positive Sentiment: Piper Sandler also initiated or reiterated a buy view on ISRG, adding to the recent concentration of bullish sell-side coverage. Intuitive Surgical gets a buy from Piper Sandler
• Positive Sentiment: The da Vinci SP single-port platform is gaining traction. Rising procedures, utilization and system placements, along with expanding medical indications and international adoption, could create another significant recurring-revenue growth franchise for Intuitive Surgical. Can ISRG’s Single-Port Platform Become the Next Billion-Dollar Franchise?
• Neutral Sentiment: Analysts remain broadly optimistic, but the average brokerage recommendation may be an imperfect signal. Commentary cautions that sell-side ratings can be overly positive, leaving investors to assess ISRG’s premium valuation and upcoming earnings execution independently. Is Intuitive Surgical a Buy as Wall Street Analysts Look Optimistic?
• Negative Sentiment: Competitive pressure remains a key concern. Jim Cramer questioned the investment case because companies including Johnson & Johnson are pursuing the robotic-surgery market, potentially challenging ISRG’s leadership and valuation. Intuitive Surgical and JNJ Give Jim Cramer More Than Valuation to Consider

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $10.41 during midday trading on Friday, hitting $425.82. 779,043 shares of the company’s stock were exchanged, compared to its average volume of 2,414,883. The company has a market cap of $150.43 billion, a PE ratio of 48.76, a P/E/G ratio of 3.13 and a beta of 1.46. The firm has a 50-day moving average of $384.95 and a two-hundred day moving average of $411.17. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period last year, the firm earned $1.81 earnings per share. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Insiders Place Their Bets

In related news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the sale, the executive vice president owned 5,320 shares of the company’s stock, valued at $2,016,280. This trade represents a 6.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of Intuitive Surgical stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total value of $4,000,000.00. Following the completion of the transaction, the director owned 1,245,679 shares in the company, valued at $498,271,600. This trade represents a 0.80% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 12,370 shares of company stock worth $4,891,989. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on ISRG shares. Stifel Nicolaus cut their price objective on Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. HSBC downgraded Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 target price for the company. in a research report on Thursday, July 30th. Sanford C. Bernstein restated an “outperform” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. TD Cowen downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, July 28th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a report on Friday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $502.53.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.